Exp Mol Med.  2017 Jul;49(7):e361. 10.1038/emm.2017.106.

Rapid generation of OPC-like cells from human pluripotent stem cells for treating spinal cord injury

Affiliations
  • 1Department of Biotechnology and BK21 PLUS project for Biotechnology, Korea University, Seoul, Republic of Korea.
  • 2Institute of Animal Molecular Biotechnology, Korea University, Seoul, Republic of Korea.
  • 3Department of Pediatrics, Korea University Guro Hospital, Seoul, Republic of Korea.
  • 4Department of Physiology, Yonsei University College of Medicine, Seoul, Republic of Korea. dwkim2@yuhs.ac, jwleem@yuhs.ac
  • 5BK21 PLUS project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.

Abstract

Remyelination via the transplantation of oligodendrocyte precursor cells (OPCs) has been considered as a strategy to improve the locomotor deficits caused by traumatic spinal cord injury (SCI). To date, enormous efforts have been made to derive OPCs from human pluripotent stem cells (hPSCs), and significant progress in the transplantation of such cells in SCI animal models has been reported. The current methods generally require a long period of time (>2 months) to obtain transplantable OPCs, which hampers their clinical utility for patients with SCI. Here we demonstrate a rapid and efficient method to differentiate hPSCs into neural progenitors that retain the features of OPCs (referred to as OPC-like cells). We used cell sorting to select A2B5-positive cells from hPSC-derived neural rosettes and cultured the selected cells in the presence of signaling cues, including sonic hedgehog, PDGF and insulin-like growth factor-1. This method robustly generated neural cells positive for platelet-derived growth factor receptor-α (PDGFRα) and NG2 (~90%) after 4 weeks of differentiation. Behavioral tests revealed that the transplantation of the OPC-like cells into the spinal cords of rats with contusive SCI at the thoracic level significantly improved hindlimb locomotor function. Electrophysiological assessment revealed enhanced neural conduction through the injury site. Histological examination showed increased numbers of axon with myelination at the injury site and graft-derived myelin formation with no evidence of tumor formation. Our method provides a cell source from hPSCs that has the potential to recover motor function following SCI.


MeSH Terms

Animals
Axons
Behavior Rating Scale
Cues
Hedgehogs
Hindlimb
Humans*
Methods
Models, Animal
Myelin Sheath
Neural Conduction
Oligodendroglia
Platelet-Derived Growth Factor
Pluripotent Stem Cells*
Rats
Spinal Cord Injuries*
Spinal Cord*
Platelet-Derived Growth Factor
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr